Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-014719
Filing Date
2020-06-01
Accepted
2020-06-01 16:15:25
Documents
1
Period of Report
2020-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7405
  Complete submission text file 0000899243-20-014719.txt   8758
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Issuer) CIK: 0001680581 (see all company filings)

EIN.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Wallace Owen B. (Reporting) CIK: 0001778843 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38978 | Film No.: 20933575